Site updated at Wednesday, 22 June 2016

Living with Dementia


Merck becomes bigger Alzheimer’s player, with new trial

Merck & Co Inc has moved to the forefront of Alzheimer’s disease research by starting a mid-stage study of a drug from a new class of oral medicines that aim to shut down production of a protein associated with the memory-robbing disease.

The drugmaker said on Monday it had started the trial to evaluate… Merck becomes bigger Alzheimer’s player, with new trial   

Living with Dementia

alzheimer brain1 - experimental alzheimer's drug1 - blood thinning medications1 - peanut butter1 - wernicke's syndrome10 - deficiency of thiamine1 - neurodegeneration2 - atherosclerotic plaques2 - quit smoking1 - symptoms of dementia3 - circumscribed cerebral atrophy1 - irritability1 - degenerationist hypothesis1 - amylin deposition1 - parkinsons disease10 - early alzheimer's damage1 - alzheimer's experience1 - berrios and freeman1 - substantial hippocampal atrophy1 - tau proteins1 - reversible dementia1 - tfp5 treatment1 - biomarkers in cerebrospinal fluid1 - alzheimer's plan1 - bmi2 - alpha-synuclein diseases1 - slower overall movement1 - carl schneider1 - signs of dementia6 - sinus issues1 -